mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond

被引：3
|
作者：
Prakash, Satyendra [1 ]
机构：
[1] Univ Allahabad, Fac Sci, Ctr Biotechnol, Allahabad, India
来源：
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 2023年 / 48卷 / 05期
关键词：
INTRACELLULAR DELIVERY; HYBRID NANOPARTICLES; LIPID NANOPARTICLES; VACCINES; EFFICIENT; NANOMATERIALS; TRANSLATION; INDUCTION; IMMUNITY; DESIGN;
D O I：
10.1007/s13318-023-00849-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Messenger RNA (mRNA) has emerged as a new therapeutic agent for the prevention and treatment of a wide range of diseases. The recent achievement of the two lipid nanoparticle-mRNA vaccines developed by Moderna and Pfizer-BioNTech against coronavirus 2019 (COVID-19) disease in record time highlights the huge potential of mRNA technology and reshaping the landscape of vaccine development and the future of gene therapies. Challenges related to translational efficacy, mRNA stability, immunogenicity, and ensuring the quality of final products have been significantly improved by recent advancements in mRNA engineering and delivery. Thus, the present review aims to provide the latest innovations that incrementally overcome these issues and future directions in the context of ongoing clinical trials against infectious diseases and beyond.
引用
收藏
页码：515 / 529
页数：15
相关论文
共 50 条
  • [21] mRNA-BASED THERAPEUTICS: NEW CLASS OF MEDICINES IN REGENERATIVE MEDICINE
    Balmayor, Elizabeth Rosado
    TISSUE ENGINEERING PART A, 2022, 28 : S589 - S589
  • [22] RNA Leaders Explore New Frontiers in mRNA-Based Medications
    Raper V.
    Genetic Engineering and Biotechnology News, 2022, 42 (S2): : 12 - 16
  • [23] Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases
    Sahu, Itishri
    Haque, A. K. M. Ashiqul
    Weidensee, Brian
    Weinmann, Petra
    Kormann, Michael S. D.
    MOLECULAR THERAPY, 2019, 27 (04) : 803 - 823
  • [24] mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
    Chavda, Vivek P.
    Jogi, Gargi
    Dave, Srusti
    Patel, Bhoomika M.
    Vineela Nalla, Lakshmi
    Koradia, Krishna
    VACCINES, 2023, 11 (03)
  • [25] Potential Implications of Testing an Experimental mRNA-Based Vaccine During an Emerging Infectious Disease Pandemic
    Nichol, Ariadne A.
    AMERICAN JOURNAL OF BIOETHICS, 2020, 20 (07): : W2 - W3
  • [26] Getting ahead of the curve: a new strategy for infectious diseases
    Oppenheim, BA
    HOSPITAL MEDICINE, 2002, 63 (07): : 390 - 391
  • [27] New histidylated cationic lipids for DNA- and mRNA-based lipofection
    Kumar, VV
    Singh, RS
    Gonçalves, C
    Sandrin, P
    Pichon, C
    Midoux, P
    Chaudhuri, A
    MOLECULAR THERAPY, 2004, 9 : S258 - S259
  • [28] Perfluorocarbon-based nanomedicine: emerging strategy for diagnosis and treatment of diseases
    Tingbin Zhang
    Qian Zhang
    Jian-Hua Tian
    Jin-Feng Xing
    Weisheng Guo
    Xing-Jie Liang
    MRS Communications, 2018, 8 : 303 - 313
  • [29] TREATMENT STRATEGY BASED ON EXPERIENCE OF TREATING INTRACRANIAL INFECTIOUS ANEURYSMS
    Yoon, B.
    Park, W.
    Ahn, J. S.
    Byun, J.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 586 - 586
  • [30] Treatment Strategy Based on Experience of Treating Intracranial Infectious Aneurysms
    Park, Wonhyoung
    Ahn, Jae Sung
    Park, Jung Cheol
    Kwun, Byung Duk
    Lee, Deok Hee
    WORLD NEUROSURGERY, 2017, 97 : 351 - 359
12345